Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue
1.4 Market Analysis by Type
1.4.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Optical Technology
1.4.3 Mechanical Technology
1.4.4 Electrochemical Technology
1.5 Market by Application
1.5.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application: 2020 VS 2026
1.5.2 Heparin Therapy Monitoring
1.5.3 Coagulation Factor Deficiencies Screening
1.5.4 Coagulation Inhibitors
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Perspective (2015-2026)
2.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Growth Trends by Regions
2.2.1 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Historic Market Share by Regions (2015-2020)
2.2.3 Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Activated Partial Thromboplastin Time Testing (APTT Testing) Market Growth Strategy
2.3.6 Primary Interviews with Key Activated Partial Thromboplastin Time Testing (APTT Testing) Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Market Size
3.1.1 Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Revenue (2015-2020)
3.1.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Players (2015-2020)
3.1.3 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Concentration Ratio
3.2.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue in 2019
3.3 Activated Partial Thromboplastin Time Testing (APTT Testing) Key Players Head office and Area Served
3.4 Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Product Solution and Service
3.5 Date of Enter into Activated Partial Thromboplastin Time Testing (APTT Testing) Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Historic Market Size by Type (2015-2020)
4.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Type (2021-2026)
5 Activated Partial Thromboplastin Time Testing (APTT Testing) Breakdown Data by Application (2015-2026)
5.1 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2015-2020)
5.2 Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2015-2020)
6.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Key Players in North America (2019-2020)
6.3 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2015-2020)
6.4 North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2015-2020)
7 Europe
7.1 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2015-2020)
7.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Key Players in Europe (2019-2020)
7.3 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2015-2020)
7.4 Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2015-2020)
8 Japan
8.1 Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size (2015-2020)
8.2 Activated Partial Thromboplastin Time Testing (APTT Testing) Key Players in Japan (2019-2020)
8.3 Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2015-2020)
8.4 Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)
9 Key Players Profiles
9.1 Medtronic
9.1.1 Medtronic Company Details
9.1.2 Medtronic Business Overview and Its Total Revenue
9.1.3 Medtronic Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.1.4 Medtronic Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020))
9.1.5 Medtronic Recent Development
9.2 Abbott
9.2.1 Abbott Company Details
9.2.2 Abbott Business Overview and Its Total Revenue
9.2.3 Abbott Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.2.4 Abbott Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.2.5 Abbott Recent Development
9.3 Roche Diagnostics
9.3.1 Roche Diagnostics Company Details
9.3.2 Roche Diagnostics Business Overview and Its Total Revenue
9.3.3 Roche Diagnostics Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.3.4 Roche Diagnostics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.3.5 Roche Diagnostics Recent Development
9.4 Siemens Healthineers
9.4.1 Siemens Healthineers Company Details
9.4.2 Siemens Healthineers Business Overview and Its Total Revenue
9.4.3 Siemens Healthineers Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.4.4 Siemens Healthineers Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.4.5 Siemens Healthineers Recent Development
9.5 Haemonetics
9.5.1 Haemonetics Company Details
9.5.2 Haemonetics Business Overview and Its Total Revenue
9.5.3 Haemonetics Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.5.4 Haemonetics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.5.5 Haemonetics Recent Development
9.6 Sysmex
9.6.1 Sysmex Company Details
9.6.2 Sysmex Business Overview and Its Total Revenue
9.6.3 Sysmex Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.6.4 Sysmex Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.6.5 Sysmex Recent Development
9.7 Danaher
9.7.1 Danaher Company Details
9.7.2 Danaher Business Overview and Its Total Revenue
9.7.3 Danaher Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.7.4 Danaher Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.7.5 Danaher Recent Development
9.8 Bio-Rad Laboratories
9.8.1 Bio-Rad Laboratories Company Details
9.8.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
9.8.3 Bio-Rad Laboratories Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.8.4 Bio-Rad Laboratories Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.8.5 Bio-Rad Laboratories Recent Development
9.9 bioMerieux
9.9.1 bioMerieux Company Details
9.9.2 bioMerieux Business Overview and Its Total Revenue
9.9.3 bioMerieux Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.9.4 bioMerieux Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.9.5 bioMerieux Recent Development
9.10 Eiken Chemical
9.10.1 Eiken Chemical Company Details
9.10.2 Eiken Chemical Business Overview and Its Total Revenue
9.10.3 Eiken Chemical Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
9.10.4 Eiken Chemical Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
9.10.5 Eiken Chemical Recent Development
9.11 Life Technologies
10.11.1 Life Technologies Company Details
10.11.2 Life Technologies Business Overview and Its Total Revenue
10.11.3 Life Technologies Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
10.11.4 Life Technologies Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
10.11.5 Life Technologies Recent Development
9.12 Becton, Dickinson and Company
10.12.1 Becton, Dickinson and Company Company Details
10.12.2 Becton, Dickinson and Company Business Overview and Its Total Revenue
10.12.3 Becton, Dickinson and Company Activated Partial Thromboplastin Time Testing (APTT Testing) Introduction
10.12.4 Becton, Dickinson and Company Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
10.12.5 Becton, Dickinson and Company Recent Development
10 Analyst's Viewpoints/Conclusions
11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details
List of TablesTable 1. Activated Partial Thromboplastin Time Testing (APTT Testing) Key Market Segments
Table 2. Key Players Covered: Ranking by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue
Table 3. Ranking of Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Optical Technology
Table 6. Key Players of Mechanical Technology
Table 7. Key Players of Electrochemical Technology
Table 8. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Regions (2015-2020)
Table 12. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Activated Partial Thromboplastin Time Testing (APTT Testing) Market Growth Strategy
Table 18. Main Points Interviewed from Key Activated Partial Thromboplastin Time Testing (APTT Testing) Players
Table 19. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue by Players (2015-2020) (Million US$)
Table 20. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Players (2015-2020)
Table 21. Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) as of 2019)
Table 22. Global Activated Partial Thromboplastin Time Testing (APTT Testing) by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Product Solution and Service
Table 25. Date of Enter into Activated Partial Thromboplastin Time Testing (APTT Testing) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2015-2020) (Million US$)
Table 28. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Share by Type (2015-2020)
Table 29. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue Market Share by Type (2021-2026)
Table 30. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Share by Application (2015-2020)
Table 31. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2015-2020) (Million US$)
Table 32. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size Share by Application (2021-2026)
Table 33. North America Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share (2019-2020)
Table 35. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2015-2020) (Million US$)
Table 36. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type (2015-2020)
Table 37. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2015-2020) (Million US$)
Table 38. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application (2015-2020)
Table 39. Europe Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share (2019-2020)
Table 41. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type (2015-2020)
Table 43. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application (2015-2020)
Table 45. Japan Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue (2019-2020) (Million US$)
Table 46. Japan Key Players Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share (2019-2020)
Table 47. Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Type (2015-2020) (Million US$)
Table 48. Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type (2015-2020)
Table 49. Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size by Application (2015-2020) (Million US$)
Table 50. Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application (2015-2020)
Table 51. Medtronic Company Details
Table 52. Medtronic Business Overview
Table 53. Medtronic Product
Table 54. Medtronic Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 55. Medtronic Recent Development
Table 56. Abbott Company Details
Table 57. Abbott Business Overview
Table 58. Abbott Product
Table 59. Abbott Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 60. Abbott Recent Development
Table 61. Roche Diagnostics Company Details
Table 62. Roche Diagnostics Business Overview
Table 63. Roche Diagnostics Product
Table 64. Roche Diagnostics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 65. Roche Diagnostics Recent Development
Table 66. Siemens Healthineers Company Details
Table 67. Siemens Healthineers Business Overview
Table 68. Siemens Healthineers Product
Table 69. Siemens Healthineers Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 70. Siemens Healthineers Recent Development
Table 71. Haemonetics Company Details
Table 72. Haemonetics Business Overview
Table 73. Haemonetics Product
Table 74. Haemonetics Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 75. Haemonetics Recent Development
Table 76. Sysmex Company Details
Table 77. Sysmex Business Overview
Table 78. Sysmex Product
Table 79. Sysmex Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 80. Sysmex Recent Development
Table 81. Danaher Company Details
Table 82. Danaher Business Overview
Table 83. Danaher Product
Table 84. Danaher Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 85. Danaher Recent Development
Table 86. Bio-Rad Laboratories Business Overview
Table 87. Bio-Rad Laboratories Product
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 90. Bio-Rad Laboratories Recent Development
Table 91. bioMerieux Company Details
Table 92. bioMerieux Business Overview
Table 93. bioMerieux Product
Table 94. bioMerieux Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 95. bioMerieux Recent Development
Table 96. Eiken Chemical Company Details
Table 97. Eiken Chemical Business Overview
Table 98. Eiken Chemical Product
Table 99. Eiken Chemical Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 100. Eiken Chemical Recent Development
Table 101. Life Technologies Company Details
Table 102. Life Technologies Business Overview
Table 103. Life Technologies Product
Table 104. Life Technologies Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 105. Life Technologies Recent Development
Table 106. Becton, Dickinson and Company Company Details
Table 107. Becton, Dickinson and Company Business Overview
Table 108. Becton, Dickinson and Company Product
Table 109. Becton, Dickinson and Company Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020) (Million US$)
Table 110. Becton, Dickinson and Company Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Type: 2020 VS 2026
Figure 2. Optical Technology Features
Figure 3. Mechanical Technology Features
Figure 4. Electrochemical Technology Features
Figure 5. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Application: 2020 VS 2026
Figure 6. Heparin Therapy Monitoring Case Studies
Figure 7. Coagulation Factor Deficiencies Screening Case Studies
Figure 8. Coagulation Inhibitors Case Studies
Figure 9. Others Case Studies
Figure 10. Activated Partial Thromboplastin Time Testing (APTT Testing) Report Years Considered
Figure 11. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Regions: 2020 VS 2026
Figure 13. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Activated Partial Thromboplastin Time Testing (APTT Testing) Market Share by Players in 2019
Figure 16. Global Top Activated Partial Thromboplastin Time Testing (APTT Testing) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Activated Partial Thromboplastin Time Testing (APTT Testing) as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Activated Partial Thromboplastin Time Testing (APTT Testing) Revenue in 2019
Figure 18. North America Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Activated Partial Thromboplastin Time Testing (APTT Testing) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Medtronic Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 23. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Abbott Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 25. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Diagnostics Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 27. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Siemens Healthineers Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 29. Haemonetics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Haemonetics Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 31. Sysmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Sysmex Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 33. Danaher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Danaher Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 35. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Bio-Rad Laboratories Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 37. bioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. bioMerieux Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 39. Eiken Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Eiken Chemical Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 41. Life Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Life Technologies Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 43. Becton, Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Becton, Dickinson and Company Revenue Growth Rate in Activated Partial Thromboplastin Time Testing (APTT Testing) Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation